(Q33214115)

24 July 2017

Formulation and evaluation of aerosolized celecoxib for the treatment of lung cancer (English)

1 reference

24 July 2017

Alfred Haynes

1

1 reference

24 July 2017

Madhu Sudhan Shaik

series ordinal

2

1 reference

24 July 2017

Abhijit Chatterjee

series ordinal

3

1 reference

24 July 2017

M Singh

series ordinal

4

1 reference

24 July 2017

1 March 2005

1 reference

24 July 2017

Pharmaceutical Research

1 reference

24 July 2017

22

1 reference

24 July 2017

3

1 reference

24 July 2017

427-439

1 reference

24 July 2017

Cancer statistics, 1998.

1 reference

12 December 2020

Enhancement of chemotherapeutic drug toxicity to human tumour cells in vitro by a subset of non-steroidal anti-inflammatory drugs (NSAIDs)

1 reference

12 December 2020

Synergistic effects of new chemopreventive agents and conventional cytotoxic agents against human lung cancer cell lines.

1 reference

12 December 2020

Lipoxygenase modulation to reverse carcinogenesis.

1 reference

12 December 2020

Non-small cell lung cancer cycloxygenase activity and proliferation are inhibited by non-steroidal antiinflammatory drugs

1 reference

12 December 2020

Evaluation of an aerosolized selective COX-2 inhibitor as a potentiator of doxorubicin in a non-small-cell lung cancer cell line

1 reference

12 December 2020

Clinical evaluation of the delivery and safety of aerosolized liposomal 9-nitro-20(s)-camptothecin in patients with advanced pulmonary malignancies.

1 reference

12 December 2020

Lung cancer--time to move on from chemotherapy

1 reference

12 December 2020

Inhaled glucocorticoids for asthma

1 reference

12 December 2020

Inhalation delivery of anticancer agents via HFA-based metered dose inhaler using methotrexate as a model drug

1 reference

12 December 2020

Cyclooxygenase-2 overexpression is a marker of poor prognosis in stage I non-small cell lung cancer

1 reference

12 December 2020

Inhaled aerosolization of all-trans-retinoic acid for targeted pulmonary delivery

1 reference

12 December 2020

Celecoxib exhibits the greatest potency amongst cyclooxygenase (COX) inhibitors for growth inhibition of COX-2-negative hematopoietic and epithelial cell lines

1 reference

12 December 2020

Cyclooxygenase-2 inhibitor induces apoptosis and enhances cytotoxicity of various anticancer agents in non-small cell lung cancer cell lines

1 reference

12 December 2020

Cyclooxygenase-2 level and culture conditions influence NS398-induced apoptosis and caspase activation in lung cancer cells.

1 reference

12 December 2020

Camptothecins and lung cancer: improved delivery systems by aerosol

1 reference

12 December 2020

An investigation of the solubility of various compounds in the hydrofluoroalkane propellants and possible model liquid propellants

1 reference

12 December 2020

Effect of chemopreventive agents on separate stages of progression of benzo[ ]pyrene induced lung tumors in A/J mice

1 reference

12 December 2020

Paclitaxel (taxol) and taxoid derivates for lung cancer treatment: potential for aerosol delivery

1 reference

12 December 2020

Novel vitamin E analogue decreases syngeneic mouse mammary tumor burden and reduces lung metastasis

1 reference

12 December 2020

Significant growth inhibition of human lung cancer cells both in vitro and in vivo by the combined use of a selective cyclooxygenase 2 inhibitor, JTE-522, and conventional anticancer agents.

1 reference

12 December 2020

Cyclooxygenase-2 modulates cellular growth and promotes tumorigenesis.

1 reference

12 December 2020

Growth inhibition of established B16-F10 lung metastases by sequential aerosol delivery of p53 gene and 9-nitrocamptothecin

1 reference

12 December 2020

Inhalation of aerosolized vitamin a: reversibility of metaplasia and dysplasia of human respiratory epithelia -- a prospective pilot study.

1 reference

12 December 2020

Inhibition of COX-2 in colon cancer cell lines by celecoxib increases the nuclear localization of active p53

1 reference

12 December 2020

Improved delivery of inhaled steroids to the large and small airways

1 reference

12 December 2020

Characterization of leukotriene A4 synthase from murine mast cells: evidence for its identity to arachidonate 5-lipoxygenase

1 reference

12 December 2020

Decreased lung tumorigenesis in mice genetically deficient in cytosolic phospholipase A2.

1 reference

12 December 2020

Antitumor effects of lipoxygenase inhibitors on murine bladder cancer cell line (MBT-2)

1 reference

12 December 2020

Mechanisms underlying nonsteroidal antiinflammatory drug-mediated apoptosis

1 reference

12 December 2020

Cancer statistics, 2001

1 reference

12 December 2020

10.1007/S11095-004-1881-Z

Identifiers

DOI

1 reference

24 July 2017

1 reference